Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania. more
Time Frame | POAI | Sector | S&P500 |
---|---|---|---|
1-Week Return | -28.99% | 0.31% | -1.26% |
1-Month Return | 60% | 0.6% | -4.16% |
3-Month Return | 95.15% | -9.44% | -0.46% |
6-Month Return | 8.11% | -5.15% | 3.58% |
1-Year Return | -58.19% | 0.33% | 22.47% |
3-Year Return | -93.27% | 4.53% | 25.13% |
5-Year Return | -97.83% | 35.98% | 77.7% |
10-Year Return | -100% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.41M | 1.25M | 1.42M | 1.51M | 1.78M | [{"date":"2019-12-31","value":79.3,"profit":true},{"date":"2020-12-31","value":70.35,"profit":true},{"date":"2021-12-31","value":79.81,"profit":true},{"date":"2022-12-31","value":84.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 531.81K | 447.19K | 487.02K | 505.11K | 634.80K | [{"date":"2019-12-31","value":83.78,"profit":true},{"date":"2020-12-31","value":70.45,"profit":true},{"date":"2021-12-31","value":76.72,"profit":true},{"date":"2022-12-31","value":79.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 879.75K | 805.08K | 933.66K | 1.00M | 1.15M | [{"date":"2019-12-31","value":76.81,"profit":true},{"date":"2020-12-31","value":70.29,"profit":true},{"date":"2021-12-31","value":81.52,"profit":true},{"date":"2022-12-31","value":87.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 62.32% | 64.29% | 65.72% | 66.45% | 64.34% | [{"date":"2019-12-31","value":93.79,"profit":true},{"date":"2020-12-31","value":96.75,"profit":true},{"date":"2021-12-31","value":98.9,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.83,"profit":true}] |
Operating Expenses | 14.65M | 13.29M | 14.41M | 16.27M | 15.13M | [{"date":"2019-12-31","value":90.08,"profit":true},{"date":"2020-12-31","value":81.69,"profit":true},{"date":"2021-12-31","value":88.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93,"profit":true}] |
Operating Income | (13.77M) | (666.27K) | (13.47M) | (15.27M) | (13.92M) | [{"date":"2019-12-31","value":-1377449300,"profit":false},{"date":"2020-12-31","value":-66626700,"profit":false},{"date":"2021-12-31","value":-1347156400,"profit":false},{"date":"2022-12-31","value":-1526771500,"profit":false},{"date":"2023-12-31","value":-1392132800,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (19.39M) | (25.88M) | (20.32M) | (25.74M) | (13.98M) | [{"date":"2019-12-31","value":-1939076600,"profit":false},{"date":"2020-12-31","value":-2588439700,"profit":false},{"date":"2021-12-31","value":-2031883200,"profit":false},{"date":"2022-12-31","value":-2573763400,"profit":false},{"date":"2023-12-31","value":-1398396700,"profit":false}] |
Income Taxes | 8.17M | 11.82M | (661.66K) | 10.47M | 4.00 | [{"date":"2019-12-31","value":69.1,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-5.6,"profit":false},{"date":"2022-12-31","value":88.6,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (19.39M) | (25.88M) | (19.66M) | (25.74M) | (18.42M) | [{"date":"2019-12-31","value":-1939076600,"profit":false},{"date":"2020-12-31","value":-2588439700,"profit":false},{"date":"2021-12-31","value":-1965717400,"profit":false},{"date":"2022-12-31","value":-2573763400,"profit":false},{"date":"2023-12-31","value":-1842473000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (27.56M) | (37.70M) | (19.66M) | (36.21M) | (13.98M) | [{"date":"2019-12-31","value":-2755613300,"profit":false},{"date":"2020-12-31","value":-3770166900,"profit":false},{"date":"2021-12-31","value":-1965717400,"profit":false},{"date":"2022-12-31","value":-3620755300,"profit":false},{"date":"2023-12-31","value":-1398396700,"profit":false}] |
EPS (Diluted) | (2.45) | (5.15) | (0.37) | (0.35) | (3.48) | [{"date":"2019-12-31","value":-245.07,"profit":false},{"date":"2020-12-31","value":-515,"profit":false},{"date":"2021-12-31","value":-37,"profit":false},{"date":"2022-12-31","value":-35,"profit":false},{"date":"2023-12-31","value":-348.41,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
POAI | |
---|---|
Cash Ratio | 0.81 |
Current Ratio | 1.20 |
Quick Ratio | 1.06 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
POAI | |
---|---|
ROA (LTM) | -55.80% |
ROE (LTM) | -149.36% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
POAI | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.74 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.26 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
POAI | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 5.19 |
P/B | 4.61 |
Price/FCF | NM |
EV/R | 5.65 |
EV/Ebitda | NM |
Predictive Oncology Inc (POAI) share price today is $1.2
Yes, Indians can buy shares of Predictive Oncology Inc (POAI) on Vested. To buy Predictive Oncology Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in POAI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Predictive Oncology Inc (POAI) via the Vested app. You can start investing in Predictive Oncology Inc (POAI) with a minimum investment of $1.
You can invest in shares of Predictive Oncology Inc (POAI) via Vested in three simple steps:
The 52-week high price of Predictive Oncology Inc (POAI) is $3.76. The 52-week low price of Predictive Oncology Inc (POAI) is $0.55.
The price-to-earnings (P/E) ratio of Predictive Oncology Inc (POAI) is
The price-to-book (P/B) ratio of Predictive Oncology Inc (POAI) is 4.61
The dividend yield of Predictive Oncology Inc (POAI) is 0.00%
The market capitalization of Predictive Oncology Inc (POAI) is $8.00M
The stock symbol (or ticker) of Predictive Oncology Inc is POAI